Effects of zinc supplementation on the anthropometric measurements, lipid profiles and fasting blood glucose in the healthy obese adults

Advanced Pharmaceutical Bulletin

Volumn 3, Issue 1, 2013, Pages 161-165

  Payahoo, Laleh ^a   Ostadrahimi, Alireza ^a   Mobasseri, Majid ^a   Bishak, Yaser Khaje ^a   Farrin, Nazila ^a   Jafarabadi, Mohammad Asghari ^a   Mahluji, Sepide ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Anthropometric measurements; Fasting blood glucose; Lipid profile; Obesity

Indexed keywords

CHOLESTEROL; GLUCONATE ZINC; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE;

EID: 84874969396     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2013.027     Document Type: Article

References (41)

1. Malekzadeh R, Mohamadnejad M, Merat Sh, Pourshams A, Etemadi A. Obesity Pandemic: an Iranian perspective. Arch Iranian Med 2005;8(1):1-7.
2. Sola E, Jover A, Lopez-Ruiz A, Jarabo M, Vaya A, Morillas C, et al. Parameters of inflammation in morbid obesity: Lack of effect of moderate weight loss. Obes Surg 2009;19(5):571-6.
3. Ford ES. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S. Diabetes Care 2005;28(11):2745-9.
4. O'Kane JW, Teitz CC, Fontana SM, Lind BK. Prevalence of obesity in adult population of former college rowers. J Am Board Fam Pract 2002;15(6):451-6.
5. WHO. Obesity and overweight fact sheet [data base on the internet] UK: WHO Media centre; 2012; cited 2012 December; Available from: www.who.int/mediacentre/factsheets/fs311/en.
6. Ayatollahi SMT, Ghoreshizade Z. prevalence of obesity and overweight among adults in Iran. Obesity Rev 2010;10:335-7.
7. Lands WE. Long-term fat intake and biomarkers. Am J Clin Nutr 1995;61(3 Suppl):721S-5S.
8. Frayn KN. Visceral fat and insulin resistance--causative or correlative? Br J Nutr 2000;83 Suppl 1:S71-7.
9. Mataix J, Lopez-Frias M, Martinez-de-Victoria E, Lopez-Jurado M, Aranda P, Llopis J. Factors associated with obesity in an adult mediterranean population: Influence on plasma lipid profile. J Am Coll Nutr 2005;24(6):456-65.
10. Marreiro DN, Fisberg M, Cozzolino SM. Zinc nutritional status and its relationships with hyperinsulinemia in obese children and adolescents. Biol Trace Elem Res 2004;100(2):137-49.
11. Marreiro DN, Geloneze B, Tambascia MA, Lerario AC, Halpern A, Cozzolino SM. Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol Trace Elem Res 2006;112(2):109-18.
12. Konukoglu D, Turhan MS, Ercan M, Serin O. Relationship between plasma leptin and zinc levels and the effect of insulin and oxidative stress on leptin levels in obese diabetic patients. J Nutr Biochem 2004;15(12):757-60.
13. Garcia OP, Long KZ, Rosado JL. Impact of micronutrient deficiencies on obesity. Nutr Rev 2009;67(10):559-72.
14. Richards BK, Steenhuis TS, Peverly JH, McBride MB, Perrone L, Gialanella G, et al. Zinc, copper, and iron in obese children and adolescents. Nutr Res 1998;18:183-9.
15. Chen MD, Lin PY, Sheu WH. Zinc status in plasma of obese individuals during glucose administration. Biol Trace Elem Res 1997;60(1-2):123-9.
16. Song Y, Wang J, Li XK, Cai L. Zinc and the diabetic heart. Biometals 2005;18(4):325-32.
17. Simon SF, Taylor CG. Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp Biol Med (Maywood) 2001;226(1):43-51.
18. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr 1998;17(2):109-15.
19. Tallman DL, Taylor CG. Effects of dietary fat and zinc on adiposity, serum leptin and adipose fatty acid composition in c57bl/6j mice. J Nutr Biochem 2003;14(1):17-23.
20. Marreiro DN, Fisberg M, Cozzolino SM. Zinc nutritional status in obese children and adolescents. Biol Trace Elem Res 2002;86(2):107-22.
21. Song MK, Rosenthal MJ, Song AM, Uyemura K, Yang H, Ament ME, et al. Body weight reduction in rats by oral treatment with zinc plus cyclo-(his-pro). Br J Pharmacol 2009;158(2):442-50.
22. Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A. Effects of weight loss in massive obesity on insulin and c-peptide dynamics: Sequential changes in insulin production, clearance, and sensitivity. J Clin Endocrinol Metab 1987;64(4):661-8.
23. Di Toro A, Marotta A, Todisco N, Ponticiello E, Collini R, Di Lascio R, et al. Unchanged iron and copper and increased zinc in the blood of obese children after two hypocaloric diets. Biol Trace Elem Res 1997;57(2):97-104.
24. Saghaei M. Random allocation software for parallel group randomized trials. BMC Med Res Methodol 2004;4(26):1-6
25. Dell RB, Holleran S, Ramakrishnan R. Sample size determination. ILAR J 2002;43(4):207-13.
26. Dabbaghmanesh MH, Kalantarhormozi MR, Soveid M, Sadeghalvad A, Ranjbar Omrani GR. Plasma zinc concentration in type 2 diabetic patients and control group in Shiraz city. Iran J Diabetes Lipid Disorders 2007;7(2):189-94.
27. Kathleen Mahan L, Escott-Stump S, Raymond JL, Krause MV. Krause's Food and the Nutrition Care Process. 13th ed. St. Louis: Elsevier Elsevier/Saunders; 2012.
28. Foster M, Petocz P, Samman S. Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: A meta-analysis of randomised controlled trials. Atherosclerosis 2010;210(2):344-52
29. Afkhami Ardekani M, Karimi M, Mohammadi M, Nourani F. Effect of Zinc Sulfate Supplementation on Lipid and Glucose in Type 2 Diabetic Patients. Pak J Nutr 2008; 7(4): 550-3.
30. Hughes S, Samman S. The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. J Am Coll Nutr 2006;25(4):285-91.
31. Hooper PL, Visconti L, Garry PJ, Johnson GE. Zinc lowers high-density lipoprotein-cholesterol levels. JAMA 1980;244(17):1960-1.
32. Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson RA. Antioxidant effects of zinc supplementation in tunisians with type 2 diabetes mellitus. J Am Coll Nutr 2003;22(4):316-21.
33. Fortes C, Agabiti N, Fano V, Pacifici R, Forastiere F, Virgili F, et al. Zinc supplementation and plasma lipid peroxides in an elderly population. Eur J Clin Nutr 1997;51(2):97-101.
34. Petering HG, Murthy L, O'Flaherty E. Influence of dietary copper and zinc on rat lipid metabolism. J Agric Food Chem 1977;25(5):1105-9.
35. Rogalska J, Brzoska MM, Roszczenko A, Moniuszko-Jakoniuk J. Enhanced zinc consumption prevents cadmium-induced alterations in lipid metabolism in male rats. Chem Biol Interact 2009;177(2):142-52.
36. Chen MD, Liou SJ, Lin PY, Yang VC, Alexander PS, Lin WH. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Biol Trace Elem Res 1998;61(3):303-11.
37. Mantzoros CS, Prasad AS, Beck FW, Grabowski S, Kaplan J, Adair C, et al. Zinc May Regulate Serum Leptin Concentrations in Humans. J Am Coll Nutr 1998;17(3):270-5.
38. Gomez-Garcia A, Hernandez-Salazar E, Gonzalez-Ortiz M, Martinez-Abundis E. Effect of oral zinc administration on insulin sensitivity, leptin and androgens in obese males. Rev Med Chil 2006;134(3):279-84.
39. Kelishadi R, Hashemipour M, Adeli K, Tavakoli N, Movahedian-Attar A, Shapouri J, et al. Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome. Metab Syndr Relat Disord 2010;8(6):505-10.
40. Prasad AS. Zinc in human health: Effect of zinc on immune cells. Mol Med 2008;14(5-6):353-7.
41. Haase H, Maret W. Protein Tyrosine Phosphatases as Targets of the combined insulinomimetric effects of zinc and oxidants. Biometals 2005;18(4):333-8.